未登录

C

Carl I. Webster

AstraZeneca

H指数:29

被引数:2,960

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intracellular Nanodelivery of DNA with Enzyme-Degradable and pH-Responsive Peptide Dendrons

利用酶可降解和pH响应性肽树突进行DNA的细胞内纳米递送

BIOMACROMOLECULES

IF5.4

2025-05-170

PRE

Acidification-Induced Structure Evolution of Lipid Nanoparticles Correlates with Their In Vitro Gene Transfections

酸化诱导的脂质纳米粒的结构演变与其体外基因转染相关

IF16

2023-01-0624

OAAI

Antibody-oligonucleotide conjugate achieves CNS delivery in animal models for spinal muscular atrophy

IF6.1

2022-12-2225

OA

FRAGLER: A Fragment Recycler Application Enabling Rapid and Scalable Modular DNA Assembly

ACS SYNTHETIC BIOLOGY

IF3.9

2022-07-073

OAAI

Bioinformatic Design of Dendritic Cell-Specific Synthetic Promoters

ACS SYNTHETIC BIOLOGY

IF3.9

2022-04-072

OAAI

Aβ31-35 Decreases Neprilysin-Mediated Alzheimer's Amyloid-β Peptide Degradation

ACS CHEMICAL NEUROSCIENCE

IF3.9

2021-09-105

PRE

Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis

使用微透析法测定抗转铁蛋白受体抗体亲和变体在大鼠中的脑药代动力学

IF7.3

2021-01-2623

OAAI

Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain

IF5.5

2019-04-2438

PREAI

A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

IF4.5

2018-05-3029

OAAI

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 (vol 14, 31, 2017)

FLUIDS AND BARRIERS OF THE CNS

IF6.2

2018-01-121

OAAI

Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system

IF7.3

2017-12-1432

OAAI

Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain

粒细胞-巨噬细胞集落刺激因子的中枢抑制在实验性神经性疼痛中具有镇痛作用

IF5.5

2017-12-1233

OAAI

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017

FLUIDS AND BARRIERS OF THE CNS

IF6.2

2017-11-0717

OAAI

Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity

IF5.5

2016-12-2043

OAAI

Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1

IF4.2

2016-02-0275

PREAI

A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donors

IF7.3

2016-01-2916

OAAI

Monovalent IgG4 molecules Immunoglobulin Fc mutations that result in a monomeric structure

IF7.3

2014-10-2728

OA

The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics

IF7.3

2014-10-2793

OAAI

Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β

IF11.7

2013-11-1973

OAAI

Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

INVESTIGATIONAL NEW DRUGS

IF2.7

2009-07-2138

PREAI